or ocular hypertension (OHT). The health technology assessment agency has specifically recommended that Roclanda be used when a fixed-dose combination (FDC) treatment has not achieved sufficient ...

"Selective laser trabeculoplasty should not only be considered an effective and safe alternative to medications as a ...

Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.

Glaucoma is a lifelong eye disease that requires regular treatment. For many, it can be controlled by a daily eye drop ...

SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.

The majority of our patients with ocular hypertension maintained IOP between 10 and 21 mm Hg across all treatment groups over time. Bai et al [4] also reported successful IOP control in their ...

NICE has recommended latanoprost–netarsudil as an option for reducing intraocular pressure (IOP) in adults with primary open-angle glaucoma or ocular hypertension when a prostaglandin analogue alone ...

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...

Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA ® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLI™, PAXTRAVA™, ELUTYX™, and Ocular ...

CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...